Exposure Clinical Trial
Official title:
A First In Human, Single Blind, Placebo Controlled, Randomized Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SP-333 Tablets in Healthy Adult Subjects
This is a randomized, phase 1, single-blind, placebo-controlled, randomized, sequential, escalating, single-dose, study designed to evaluate the safety, tolerability, pharmacodynamics (PD) and pharmacokinetics (PK) properties of orally administered SP-333 tablets.
This is a randomized, phase 1, single-blind, placebo controlled, single-dose, study designed to evaluate the safety, tolerability, and pharmacokinetic properties of orally administered SP-333 tablets. The study will include 7 groups of 8 subjects each (6 active, 2 placebo) given a single oral dose of of SP-333 tablets or placebo. Following outpatient screening from approximately 5 to 42 days before dosing, each subject will enter the Clinical Pharmacology Unit (CPU) and will be housed from at least 48 hours, before dosing until 48 hours after dosing. Subjects will be given single dose of the study drug on the day of dosing and remain in the CPU for at least 48 hours. Subjects will return to the CPU on Days 8±1 and 15±1 for safety follow up. Safety Committee Meetings will be conducted to review safety, tolerability, and available Pharmacokinetic data from the current and previous treatment group(s), prior to dosing subsequent treatment groups. Subjects in a given treatment group are considered completers once they have completed the Day 15±1 day Follow up Visit. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04109677 -
AIM CONTROL and SWECON - Handball The SWEdish CONcussion Study in Elite Handball
|
||
Not yet recruiting |
NCT04919434 -
Intervention to Reduce Exposure to Environmental COntaminant (IRECO)
|
N/A | |
Completed |
NCT04064255 -
Evaluation of Practical Body Image Therapy for Anorexia Nervosa V1
|
N/A | |
Completed |
NCT01450969 -
New Fabric Attenuation Device in Endovascular Interventional Radiology (PREFER)
|
N/A | |
Completed |
NCT05128981 -
Internet-delivered Cognitive Behavioral Therapy Following Myocardial Infarction
|
N/A | |
Completed |
NCT03712748 -
Online Imaginal Exposure
|
N/A | |
Recruiting |
NCT04297462 -
Different Regimens in Influenza Postexposure Chemoprophylaxis in Children
|
N/A | |
Completed |
NCT05322655 -
PAthogen Transmission and Health Outcome Models of Enteric Disease
|
||
Completed |
NCT05158010 -
Advancing Tools for Human Early Lifecourse Exposome Research and Translation- Adolescence Follow-up of the HELIX Subcohort
|
N/A | |
Recruiting |
NCT06208202 -
Perceptions of E-Cigarettes and Synthetic Cooling Agents, The ICE Study
|
N/A | |
Recruiting |
NCT05079984 -
Agile Development of a Digital Exposure Treatment for Youth With Chronic Musculoskeletal Pain
|
N/A | |
Completed |
NCT01365988 -
Neutral Correlates of Risk-taking in Adolescents Exposed to Drugs Prenatally
|
||
Completed |
NCT03934697 -
Imaginal Exposure II Study: In-Vivo
|
N/A | |
Completed |
NCT01087307 -
Sample Collection Registry for Quality Control of Biological and Environmental Specimens and Assay Development and Testing
|
||
Recruiting |
NCT05869747 -
Firefighter Collaborative Research Project
|
N/A | |
Completed |
NCT03414801 -
Red Maple Trials Cat Allergen Natural Exposure Chamber Validation in Cat-allergic Subjects
|
N/A | |
Completed |
NCT02199535 -
The Analysis of the Risks of the Personnel Working in Anesthesiology Departments in Turkey
|
N/A | |
Not yet recruiting |
NCT06338800 -
One Session Virtual Reality During Ongoing Treatment for Anxiety: Feasibility in Children and Adolescents
|
N/A | |
Not yet recruiting |
NCT06323538 -
Cohort Study on Plant-based Diets (COPLANT Study)
|